MedTrace Logo

Brain Fog and Life Quality in Menopause

NCT06978218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2025-08-11

No results posted yet for this study

Summary

This clinical study aims to investigate cognitive changes in women undergoing the menopausal transition, with a specific focus on the prevalence, characteristics, and impact of brain fog. The research will assess how declining estrogen levels influence cognitive domains such as memory, attention, and executive function across different menopausal stages (perimenopause, menopause, and postmenopause). Through a comparative and observational design, the study will evaluate the relationship between subjective cognitive complaints and menopause-specific quality of life. Findings are expected to inform the development of non-pharmacological strategies-such as lifestyle modifications and cognitive health interventions-to mitigate cognitive decline and improve overall well-being in midlife women.

Conditions

  • Menopause
  • Cognitive Dysfunction
  • Memory Disorders
  • Quality of Life
  • Women's Health
  • Perimenopausal Disorder
  • Postmenopausal Symptoms

Sponsors & Collaborators

  • Merve Coskun

    lead OTHER

Principal Investigators

  • Merve Coşkun, Asst. Prof. · Acibadem University

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-08
Primary Completion
2025-07-16
Completion
2025-07-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06978218 on ClinicalTrials.gov